Recombinant EGFR (Panitumumab Biosimilar) antibody

Catalog No. ABIN7200662

This Mouse Monoclonal antibody specifically detects EGFR (Panitumumab Biosimilar) in FACS and in vivo. It exhibits reactivity toward Human.

Quick Overview for Recombinant EGFR (Panitumumab Biosimilar) antibody (ABIN7200662)

Target: EGFR (Panitumumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This EGFR (Panitumumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Product Details anti-EGFR (Panitumumab Biosimilar) Antibody

Purpose: Panitumumab Biosimilar, Human EGFR/ErbB-1/HER1 Monoclonal Antibody

Specificity: The monoclonal antibody panitumumab biosimilar specifically binds to the human EGFR, ErbB-1 and HER1.

Characteristics: Recombinant Humanized IgG2 Monoclonal Antibody.

Purification: Protein A affinity column

Purity: > 95% by SDS-PAGE under reducing conditions and HPLC.

Sterility: 0.2 μm filtered

Endotoxin Level: < 1 EU per 1 mg of the protein by the LAL method.

Immunogen: The monoclonal antibody panitumumab biosimilar was produced in the Panitumumab biosimilar CHO stable cell line.

Isotype: IgG2 kappa

Application Details

Application Notes: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by panitumumab.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: PBS, pH 7.4, no stabilizers or preservatives.

Preservative: Without preservative

Handling Advice: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

Storage: -20 °C

Storage Comment: 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.

Expiry Date: 12 months

Target Details for EGFR (Panitumumab Biosimilar)

Target: EGFR (Panitumumab Biosimilar)

Target Type: Biosimilar

Background: Panitumumab, a fully anti-EGFR (epidermal growth factor receptor, EGF receptor, ErbB-1 and HER1 in humans) human monoclonal antibody, is used for the treatment of refractory EGFR-expressing metastatic colorectal cancer in patients with non-mutated (wild-type) KRAS".